Lakefront Biotherapeutics ADR Company Profile
NASDAQ: LKFTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 29.51 0.00%
Lakefront Biotherapeutics at a glance
Lakefront Biotherapeutics ADR (NASDAQ: LKFT) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Mechelen, Belgium. Lakefront Biotherapeutics is led by Mr. Henry O. Gosebruch and employs about 196 people. The company's shares have traded publicly since 2015.
At a market capitalization of $1.93 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001421876, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Lakefront Biotherapeutics do?
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Business description based on the company's public filings.
Company information
- Legal name
- Lakefront Biotherapeutics ADR
- Ticker
- NASDAQ: LKFT
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Henry O. Gosebruch
- Employees
- 196
- Headquarters
- SchaliEnhoevedreef 20 T, Mechelen, Belgium
- Phone
- 32 1 534 29 00
- Website
- lakefrontbio.com
- IPO year
- 2015
- Market cap
- $1.93B
- SEC CIK
- 0001421876
Companies similar to Lakefront Biotherapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SRPTSarepta Therapeutics Inc. | 18.21 | +4.06% | $1.92B | vs LKFT |
| AGIOAgios Pharmaceuticals Inc. | 31.92 | +0.41% | $1.91B | vs LKFT |
| PVLAPalvella Therapeutics Inc. | 131.34 | +0.57% | $1.89B | vs LKFT |
| SDGRSchrodinger Inc. | 26.39 | -3.30% | $1.97B | vs LKFT |
| ADRXADARx Pharmaceuticals Inc. | 17.68 | +1.99% | $1.89B | vs LKFT |
| MLYSMineralys Therapeutics Inc. | 22.38 | +1.31% | $1.98B | vs LKFT |
| PRGOPerrigo Company plc | 14.50 | -0.34% | $2.01B | vs LKFT |
| XERSXeris Biopharma Holdings Inc. | 10.19 | +0.79% | $1.86B | vs LKFT |